These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 8552399

  • 1. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
    Kataoka K, Noda M, Nishizawa M.
    Oncogene; 1996 Jan 04; 12(1):53-62. PubMed ID: 8552399
    [Abstract] [Full Text] [Related]

  • 2. c-Jun inhibits NF-E2 transcriptional activity in association with p18/maf in Friend erythroleukemia cells.
    Francastel C, Augery-Bourget Y, Prenant M, Walters M, Martin DI, Robert-Lézénès J.
    Oncogene; 1997 Feb 20; 14(7):873-7. PubMed ID: 9047395
    [Abstract] [Full Text] [Related]

  • 3. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor.
    Kataoka K, Igarashi K, Itoh K, Fujiwara KT, Noda M, Yamamoto M, Nishizawa M.
    Mol Cell Biol; 1995 Apr 20; 15(4):2180-90. PubMed ID: 7891713
    [Abstract] [Full Text] [Related]

  • 4. Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif.
    Toki T, Itoh J, Kitazawa J, Arai K, Hatakeyama K, Akasaka J, Igarashi K, Nomura N, Yokoyama M, Yamamoto M, Ito E.
    Oncogene; 1997 Apr 24; 14(16):1901-10. PubMed ID: 9150357
    [Abstract] [Full Text] [Related]

  • 5. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK, Curran T.
    Oncogene; 1994 Mar 24; 9(3):675-84. PubMed ID: 8108109
    [Abstract] [Full Text] [Related]

  • 6. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH.
    Oncogene; 1998 May 28; 16(21):2711-21. PubMed ID: 9652737
    [Abstract] [Full Text] [Related]

  • 7. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins.
    Kerppola TK, Curran T.
    Oncogene; 1994 Nov 28; 9(11):3149-58. PubMed ID: 7936637
    [Abstract] [Full Text] [Related]

  • 8. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins.
    Igarashi K, Kataoka K, Itoh K, Hayashi N, Nishizawa M, Yamamoto M.
    Nature; 1994 Feb 10; 367(6463):568-72. PubMed ID: 8107826
    [Abstract] [Full Text] [Related]

  • 9. Rat maf-related factors: the specificities of DNA binding and heterodimer formation.
    Matsushima-Hibiya Y, Nishi S, Sakai M.
    Biochem Biophys Res Commun; 1998 Apr 17; 245(2):412-8. PubMed ID: 9571165
    [Abstract] [Full Text] [Related]

  • 10. [Study of rat maf-related gene products: recognition DNA sequences and heterodimer-formation].
    Hibiya Y.
    Hokkaido Igaku Zasshi; 1997 Jan 17; 72(1):69-83. PubMed ID: 9086364
    [Abstract] [Full Text] [Related]

  • 11. mafA, a novel member of the maf proto-oncogene family, displays developmental regulation and mitogenic capacity in avian neuroretina cells.
    Benkhelifa S, Provot S, Lecoq O, Pouponnot C, Calothy G, Felder-Schmittbuhl MP.
    Oncogene; 1998 Jul 16; 17(2):247-54. PubMed ID: 9674710
    [Abstract] [Full Text] [Related]

  • 12. Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain.
    Fujiwara KT, Kataoka K, Nishizawa M.
    Oncogene; 1993 Sep 16; 8(9):2371-80. PubMed ID: 8361754
    [Abstract] [Full Text] [Related]

  • 13. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR, Tae HJ, Mitin N, Taparowsky EJ.
    Oncogene; 2000 Mar 30; 19(14):1752-63. PubMed ID: 10777209
    [Abstract] [Full Text] [Related]

  • 14. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun.
    Kataoka K, Noda M, Nishizawa M.
    Mol Cell Biol; 1994 Jan 30; 14(1):700-12. PubMed ID: 8264639
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of action of a dominant-negative mutant of c-Jun.
    Brown PH, Chen TK, Birrer MJ.
    Oncogene; 1994 Mar 30; 9(3):791-9. PubMed ID: 8108121
    [Abstract] [Full Text] [Related]

  • 16. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K, Colburn NH.
    Oncogene; 2002 Mar 28; 21(14):2181-90. PubMed ID: 11948401
    [Abstract] [Full Text] [Related]

  • 17. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
    Kim S, Brown PH, Birrer MJ.
    Oncogene; 1996 Mar 07; 12(5):1043-53. PubMed ID: 8649795
    [Abstract] [Full Text] [Related]

  • 18. Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.
    Morgan IM, Asano M, Håvarstein LS, Ishikawa H, Hiiragi T, Ito Y, Vogt PK.
    Oncogene; 1993 May 07; 8(5):1135-40. PubMed ID: 8479738
    [Abstract] [Full Text] [Related]

  • 19. The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene.
    Andrews NC, Kotkow KJ, Ney PA, Erdjument-Bromage H, Tempst P, Orkin SH.
    Proc Natl Acad Sci U S A; 1993 Dec 15; 90(24):11488-92. PubMed ID: 8265578
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells.
    Chuen CK, Li K, Yang M, Fok TF, Li CK, Chui CM, Yuen PM.
    J Lab Clin Med; 2004 Feb 15; 143(2):75-88. PubMed ID: 14966463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.